Not all patients with CLL require therapy. Regardless of all recent improvements, the iwCLL still suggests watchful observation for sufferers with asymptomatic condition.86 This suggestion is predicated on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F